PetIQ, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
PetIQ, a leader in pet medication and wellness, is set to release its financial results for the first quarter ending March 31, 2023, on May 9, 2023, after market close. The company will host a conference call at 4:30 p.m. ET on the same day to discuss these results. North American participants can join the call by dialing 844-826-3033, while international listeners should call 412-317-5185. The conference will also be streamed live on the company’s website. PetIQ offers affordable veterinary products and operates over 2,600 retail partner locations through VIP Petcare, ensuring convenient access to pet wellness. The organization emphasizes the importance of high-quality care for pets, engaging customers via more than 60,000 distribution points across various channels.
- PetIQ operates over 60,000 distribution points, enhancing product accessibility.
- The company provides services through more than 2,600 retail partner locations, catering to a wide market.
- None.
EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2023, on Tuesday, May 9, 2023, after the market close.
The Company will host a conference call with members of the executive management team to discuss these results. The conference call is scheduled to begin at 4:30 p.m. ET on Tuesday, May 9, 2023. To participate on the live call listeners in North America may dial 844-826-3033 and international listeners may dial 412-317-5185.
In addition, the call will be broadcast live over the Internet hosted at the “Investors” section of the Company’s website at www.PetIQ.com. A telephonic playback will be available through Tuesday, May 30, 2023. North American listeners may dial 844-512-2921 and international listeners may dial 412-317-6671; the passcode is 10177412.
About PetIQ
PetIQ is a leading pet medication and wellness company delivering a smarter way for pet parents to help their pets live their best lives through convenient access to affordable veterinary products and services. The company engages with customers through more than 60,000 points of distribution across retail and e-commerce channels with its branded and distributed medications, which is further supported by its own world-class medications manufacturing facility in Omaha, Nebraska. The company’s national service platform, VIP Petcare, operates in over 2,600 retail partner locations in 41 states providing cost effective and convenient veterinary wellness services. PetIQ believes that pets are an important part of the family and deserve the best products and care we can give them.
Contact
Investors: katie.turner@petiq.com or 208.513.1513
Media: kara.schafer@petiq.com or 407.929.6727
FAQ
When will PetIQ report its financial results for the first quarter of 2023?
What time is the PetIQ conference call to discuss financial results?
How can I participate in PetIQ's financial results conference call?